SWP
IOVA icon

Stratos Wealth Partners’s Iovance Biotherapeutics IOVA Stock Holding History

Stratos Wealth Partners’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-13,974
Closed -$267K – 1306
2021
Q4 		$267K Sell
13,974
-1,450
-9% -$31.9K 0.01% 1043
2021
Q3 		$380K Sell
15,424
-6,252
-29% -$147K 0.01% 862
2021
Q2 		$564K Sell
21,676
-27,165
-56% -$706K 0.01% 730
2021
Q1 		$1.55M Sell
48,841
-769
-2% -$31.9K 0.04% 376
2020
Q4 		$2.3M Buy
49,610
+8,298
+20% +$329K 0.07% 257
2020
Q3 		$1.36M Sell
41,312
-8,411
-17% -$258K 0.04% 324
2020
Q2 		$1.36M Sell
49,723
-15,864
-24% -$522K 0.05% 321
2020
Q1 		$1.96M Buy
+65,587
New +$1.74M 0.09% 222

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return